Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Request a Policy / Feedback
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.32
    OpenPayerPolicy UpdatesHome Health & HospiceBlue Cross VT Home Infusion Coverage | OpenPayer
    Ask Trek AI about this page
    CurrentBlue Cross Blue Shield of VermontPolicy 8.03.VT201

    Home Infusion Therapy Corporate Medical Policy

    Customize your policy alerts

    Sign up for bcbsvermont Policy 8.03.VT201 alerts

    Get alerted when Policy 8.03.VT201 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of home infusion therapy using intravenous solutions and injectable medications administered subcutaneously or intramuscularly for eligible members, subject to benefit contract terms and drug-specific prior approval requirements.

    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyHome Infusion Therapy Corporate Medical Policy
    Policy CodePolicy 8.03.VT201
    Change TypeAdministrative and reference updatesno material coverage change
    Effective DateFebruary 1, 2027
    Last ReviewOct 1, 2026
    Next Review DateOctober 1, 2027
    Key ActionConsult the Blue Cross VT Drug Prior Approval Listing to determine whether the prescribed drug requires prior approval.
    SourceLink
    POLICY UPDATE CHANGES

    The policy was reviewed in October 2026 with no change to the policy statement, and references were updated.

    6Coverage criteria that must all be met
    3Recognized prescriber types
    3Covered administration routes
    Network/preferredRequired provider status

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Not medically necessary
    Failure to meet criteria

    Home Infusion Therapy Coverage

    Home infusion therapy medical necessity

    Home infusion therapy may be considered medically necessary when ALL of the following criteria are met:

    All criteria required

    • FDA-approved medication: The prescription drug is FDA approved.FDA approved
    • Qualified prescriber: The therapy regimen is prescribed by a medical doctor (MD or DO), physician assistant (PA), or nurse practitioner (NP).MD/DO, PA, or NP
    • Qualified home management: The therapy is managed in the home by a medical doctor (MD or DO), physician assistant (PA), nurse practitioner (NP), or registered nurse (RN).MD/DO, PA, NP, or RN
    • Safe home administration: Treatment can be safely administered in the home.Safe for home administration
    • Duration within standard of care: The prescribed home infusion therapy regimen is for a period of time that does not exceed the standard of care for the condition being treated.Duration not exceeding the standard of care
    • Eligible provider: Services are provided by a network/preferred home infusion therapy provider.Network/preferred provider

    Home infusion therapy that does not meet the policy’s medical necessity criteria is considered not medically necessary.

    Authorization, Documentation, and Compliance

    Prior Authorization

    Drug-Specific Prior Approval

    Certain drugs may require prior approval. Before providing home infusion therapy, consult the Blue Cross VT Drug Prior Approval Listing to determine whether the specific drug requires authorization.

    • Review the Blue Cross VT Drug Prior Approval Listing for applicable drugs.
    Prior Authorization

    Verify Benefits and Authorization Status

    General prior approval is not required; however, benefits remain subject to all terms, limitations, and conditions of the subscriber contract. Verify coverage before providing services because benefits may differ by member contract, group, ASO arrangement, NEHP/ABNE or Federal Employee Program status, and exclusions or Vermont legislative mandate requirements.

    • Confirm benefits with the member's health plan customer service department when applicable.
    • For FEP members, contact FEP customer service or consult the FEP Service Benefit Plan Brochure.
    • For ASO members, verify benefits through employer plan documents or customer service; employer plan language takes precedence over the medical policy.

    Infusion Therapy Overview

    Infusion therapy administers medication through a needle or catheter, most commonly intravenously, when a condition cannot be effectively treated with oral medication. Home infusion therapy may also use intravenous solutions or injectable medications administered subcutaneously or intramuscularly. Common uses include antibiotics, antifungals, antivirals, chemotherapy, hydration, pain management, and parenteral nutrition.

    Key Terms

    Infusion therapy
    DefinitionAdministration of medication through a needle or catheter, typically intravenously, and sometimes through other non-oral routes.
    Typical routeIntravenous (IV) administration.
    Other routesMay include intramuscular injections and epidural routes.
    Home infusion therapy
    DefinitionInfusion therapy delivered using intravenous solutions and/or injectable medications administered subcutaneously or intramuscularly.
    Intravenous therapyUses intravenous (IV) solutions.
    Injectable therapy
    Policy Summary
    PayerBlue Cross Blue Shield of Vermont
    PolicyHome Infusion Therapy Corporate Medical Policy
    Policy CodePolicy 8.03.VT201
    Change TypeAdministrative and reference updatesno material coverage change
    Effective DateFebruary 1, 2027
    Last ReviewOct 1, 2026
    Next Review DateOctober 1, 2027
    Key ActionConsult the Blue Cross VT Drug Prior Approval Listing to determine whether the prescribed drug requires prior approval.
    SourceLink
    On This Page
    Home Infusion Therapy CoverageAuthorization, Documentation, and ComplianceInfusion Therapy OverviewKey Terms
  1. Member contract language takes precedence over the medical policy when there is a conflict.
  2. Documentation Required

    Submit Complete Authorization Information

    Authorization requests must include complete information and demonstrate that the policy guidelines are met. Incomplete requests may delay the decision while missing information is obtained.

    • Include documentation addressing each applicable medical-necessity and home-infusion requirement.
    • Submit any information needed to establish that the requested service is covered under the member's benefit contract.

    Unsupported block type: documentation

    Denial Risk

    Failure to Meet Criteria May Result in Denial

    Home infusion therapy that does not meet the policy's medical-necessity criteria is considered not medically necessary and may be denied.

    • A denial may result when any required criterion is not satisfied.
    Denial Risk

    Meet Home Infusion Requirements

    Failure to satisfy the home infusion requirements creates a denial risk. This includes lack of FDA approval, an unqualified prescriber or home manager, inability to safely administer treatment at home, an excessive treatment duration, or use of a non-network/non-preferred provider.

    • Confirm FDA approval for the prescribed drug.
    • Verify prescriber and home-management qualifications.
    • Document safe home administration and appropriate clinical management.
    • Confirm the treatment duration is consistent with the standard of care.
    • Use a network or preferred home infusion therapy provider.
    Denial Risk

    Audit and Recoupment Risk

    Blue Cross VT reserves the right to audit any provider or facility for compliance with the medical policy. If an audit identifies noncompliance, Blue Cross VT may recoup all noncompliant payments.

    • Maintain records supporting medical necessity, authorization information, benefit verification, and compliance with home infusion requirements.
    • Noncompliant payments may be subject to recoupment.
    Medications are administered subcutaneously or intramuscularly.